Get started
Author

Aswathy R. Devan

Observed names: A. R. Devan, Aswathy R Devan, Aswathy.R. Devan
ORCID: 0000-0001-8928-8191
Observed ORCID: 0000-0001-8928-8191
OpenAlex ID: A5079050135
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
2021 · Ayana R. Kumar, Aswathy R. Devan, et al. · Molecular Biology Reports · 154
The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential
2024 · Aswathy R. Devan, Bhagyalakshmi Nair, et al. · European journal of medical research · 55
PDF
Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review
2021 · Jasmine Baby, Aswathy R. Devan, et al. · Journal of Food Biochemistry · 53
PDF
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
2022 · Aswathy R Devan, Keechilat Pavithran, et al. · World Journal of Gastroenterology · 38
Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
2021 · Ayana R. Kumar, Aswathy R. Devan, et al. · Current Drug Targets · 30
Mucus targeting as a plausible approach to improve lung function in COVID-19 patients
2021 · Sarath S. Kumar, Aiswarya Binu, et al. · Medical Hypotheses · 25
An insight into the role of telmisartan as PPAR‐γ/α dual activator in the management of nonalcoholic fatty liver disease
2021 · Aswathy R. Devan, Bhagyalakshmi Nair, et al. · Biotechnology and Applied Biochemistry · 20
Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance
2021 · M. Murali, A. R. Kumar, et al. · Clinical & Translational Oncology · 19
Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma
2021 · Aswathy R. Devan, Ayana R. Kumar, et al. · Pharmaceuticals · 19
PDF
The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
2020 · Bilha Baby, Aswathy R Devan, et al. · Infectious Disorders - Drug Targets · 19
Kaempferide exhibits an anticancer effect against hepatocellular carcinoma in vitro and in vivo
2023 · Gopika Chandrababu, Merlin Varkey, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 17
Translational Phytomedicines against Cancer: Promise and Hurdles
2022 · Aswathy R Devan, Bhagyalakshmi Nair, et al. · Advanced Pharmaceutical Bulletin · 17
PDF
Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: Therapeutic insights and strategies
2024 · Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, et al. · Drug Discovery Today · 15
Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies
2025 · Sunil Kumar Sah, S.A. Ajay, et al. · International Journal of Pharmaceutics · 13
Unravelling the Immune Modulatory Effect of Indian Spices to Impede the Transmission of COVID-19: A Promising Approach
2021 · Aswathy R. Devan, Bhagyalakshmi Nair, et al. · Current Pharmaceutical Biotechnology · 12
Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
2023 · Aswathy R. Devan, Bhagyalakshmi Nair, et al. · Cancers · 6
PDF
Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma
2022 · Lekshmi R. Nath, Ayana R. Kumar, et al. · Current Cancer Drug Targets · 6
Hyaluronic acid-based drug delivery systems for targeted cancer therapy
2023 · Aswathy R. Devan, Sunil Kumar Sah, et al. · Elsevier eBooks · 4
Click inspired new series of pyridazine-triazole-persulfonimide derivatives as DPP-4 inhibitors with exploratory HepG2 phenotypic screening
2026 · Manisha Nidhar, Vipin Kumar, et al. · Bioorganic Chemistry · 1
Ultrasound imaging-guided protocol for monitoring tumor growth in orthotopic rat model of hepatocellular carcinoma
2025 · Aswathy R Devan, Sithara Manakkaparambil Sasidharan, et al. · World Journal of Hepatology · 1
PDF
Host Defense Peptides for Intracellular Bacterial Infections: Overcoming Translational Barriers Through Peptide Engineering and Nanotechnology-Based Drug Delivery Systems
2026 · Aswathy R. Devan, Pradeesh Babu, et al. · Pharmaceutics
Gut microbiota and pediatric metabolic dysfunction–associated steatotic liver disease: clinical evidence and therapeutic implications
2026 · Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, et al. · Frontiers in Pediatrics
PDF
PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials
2026 · Ayana R. Kumar, M. Divya Dharshini, et al. · Scientific Reports
PDF
Precision Medicine in Liver Cancer
2026 · Adithya Jayaprakash Kamath, Siva S., et al. · Cancer drug discovery and develogment/Cancer drug discovery and development
Contributors
2026 · Dorsa Alijanzadeh, Chandra Sekhar Bhol, et al. · Elsevier eBooks
Works count: 30
Citation count: 524
H-index: 13
I10-index: 15
Year
Topic
Type